Go east

Pliva, the Croatian drugs maker, is the subject of a $2bn bidding war, following a wave of foreign takeovers of Eastern European groups. The reason? Generic drug sales are going gangbusters. And low labour costs and EU expansion means the Eastern Europeans are in a sweet spot.